Cumberland Pharmaceuticals (CPIX) shares surged 132% in recent Tuesday premarket activity, a day after it said the US Food and Drug Administration approved its supplemental new drug application for acetadote, simplifying the administration of the dosing regimen.
Cardiff Oncology (CRDF) stock soared 38% after it said that initial results from a phase 2 clinical trial of its cancer treatment candidate onvansertib demonstrated an overall 57% objective response rate in participants with a specific metastatic colorectal cancer.
Alaska Air Group (ALK) shares were up 11% after it launched new nonstop connections from Seattle to Tokyo and Seoul starting next year and issued better-than-expected 2025 earnings per share guidance.
American Airlines Group (AAL) stock was 3% higher after Bernstein upgraded it to outperform from market perform and raised its price target to $24 from $14.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。